Arcus Biosciences Inc (RCUS) — Capital Reinvestment Ratio
Arcus Biosciences Inc (RCUS) has a Capital Reinvestment Ratio of 0.04x as of September 2024, meaning it reinvests 0% of its operating cash flow ($26.00 Million) in capital expenditures ($1.00 Million). See Arcus Biosciences Inc net asset quality index to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Arcus Biosciences Inc Capital Reinvestment Ratio (2020–2022)
This chart tracks Arcus Biosciences Inc's Capital Reinvestment Ratio across 2 annual periods. Check Arcus Biosciences Inc cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Arcus Biosciences Inc (2020–2022)
Year-by-year Capital Reinvestment Ratio for Arcus Biosciences Inc from 2020 to 2022. For live market cap and broader valuation context, see Arcus Biosciences Inc market cap and net worth.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2022 | 0.01x | $438.00 Million | $6.00 Million | ▼ -50.2% |
| 2020 | 0.03x | $111.17 Million | $3.06 Million | — |